Stay updated with breaking news from Eceptor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon. Their findings, published today (12 October) in Nature Communications, could lead to the first effective treatments for people with Raynaud’s.
The interplay among chronic kidney disease, metabolic risk factors, and the cardiovascular system.
The benefits of consuming nutrients, prebiotics, and probiotics to enhance cardiovascular and renal health.
In this interview, NewsMedical talks to James Brady about cell-based therapy and how the field of genetic engineering transformed.
In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows.